

home :: contact us :: search :: sitemap
ABS supports our sponsors with an expertise developed from two decades of designing, implementing, and managing successful registries and prospective observational studies on a global scale in a variety of therapeutic areas. Clients use our registry programs for risk management and value demonstration, focusing on the critical clinical, economic, outcome, pharmacovigilance, and marketing issues that complement and expand upon the knowledge base produced in controlled clinical trials.
Registries offer value both at the pre-approval stage, in assessing baseline clinical practice patterns and optimizing the initial approach to market, and at the post-approval stage, where marketing strategies must be continually adjusted as the marketplace evolves and the regulatory environment changes. ABS understands how and why registries are different from clinical trials, and how to use the building blocks of registry design to construct programs specifically tailored to address critical clinical and business objectives.
For the routine tasks of a trial, study, or registry, sponsors can select from many CROs. For complex or strategic issues, however, clients turn to ABS because we provide access to interdisciplinary teams of health economists, clinicians, and biostatisticians who deliver customized solutions designed specifically for their needs. Our integrated approach to registry design, management, and operations delivers turnkey research and analytic services that are cost-effective, coordinated, and feature a single point of contact.
Our registries team is comprised of senior professional staff who partner with clients to create registry programs that are effective, flexible, and cost-effective vehicles for obtaining the intelligence needed to support clinical, business, and marketing strategy. By collecting and analyzing information on product usage, ABS registries arm our sponsors with the knowledge and insight required for successful product launch, in-market brand management, and long-term product growth in a competitive global marketplace.